Psychedelics Amplify Brain Connectivity Through Serotonin Receptors, Study Suggests

A new study reveals how psychedelics like psilocybin, LSD, DMT, and mescaline fundamentally alter brain connectivity by acting on serotonin receptors, offering insights into their mechanism of action. Researchers emphasize that understanding these basic neurological mechanisms is crucial for developing effective treatments, as psychedelics show promise for depression, anxiety, addiction, and other mental health conditions. After decades of scientific neglect, these substances are now undergoing rigorous investigation to bridge the gap between their therapeutic potential and fundamental neuroscience. This foundational knowledge could accelerate the development of psychedelic-assisted therapies and improve treatment outcomes for patients suffering from various psychiatric disorders.